3886211000001102: Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \UK product\Virtual medicinal product\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \UK product\Virtual therapeutic moiety\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \UK product\Virtual therapeutic moiety\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \UK product\Trade family\Corgaretic\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing nadolol in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing nadolol\Product containing nadolol in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing nadolol\Product containing nadolol in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing nadolol in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing nadolol in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet\Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
17989101000001118	Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
17989201000001113	Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start